Review



atcc 43390  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    ATCC atcc 43390
    Atcc 43390, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 15 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/43390/Pseudomonas+aeruginosa+(Schroeter)+Migula/10__1038_slash_s44259___026___00252___1-184-1-1
    Average 94 stars, based on 15 article reviews
    atcc 43390 - by Bioz Stars, 2026-11
    94/100 stars

    Images

    Related Articles

    Variant Assay:

    Article Title: Kinetics of adaptive immune responses after administering mRNA-Based COVID-19 vaccination in individuals with and without prior SARS-CoV-2 infections.
    Article Snippet: .. The wild-type SARS-CoV-2 (BetaCoV/Korea/KCDC03/2020), Delta variant (NCCP 43,390), and Omicron- B.1.1.529 (NCCP 43,408) were purchased from the National Biobank of Korea (Cheongju, Korea) and passaged three times in VERO-E6 cells (ATCC® CRL-1586TM). .. For the PRNT assay, VERO-E6 cells were maintained in Dulbecco’s Modified Eagle’s Medium (Thermo Fisher Scientific, Waltham, Massachusetts, USA) supplemented with 2% fetal bovine serum (Thermo Fisher Scientific), penicillin (100 U/ml), and streptomycin (100 μg/ml; Thermo Fisher Scientific).

    In Vitro:

    Article Title: An Injectable Living Hydrogel with Embedded Probiotics as a Novel Strategy for Combating Multifaceted Pathogen Wound Infections.
    Article Snippet: Wound infections pose a significant challenge in healthcare, and traditional antibiotic treatments often result in the development of resistant pathogens.. Addressing this gap, we introduced ProGel, a living hydrogel created by entrapping probiotic Lactobacillus plantarum as a therapeutic component within a gelatin matrix.. With a double-syringe system, ProGel can be easily mixed and applied, conforming swiftly to any wound shape and forming hydrogel in situ.

    Probiotics:

    Article Title: An Injectable Living Hydrogel with Embedded Probiotics as a Novel Strategy for Combating Multifaceted Pathogen Wound Infections.
    Article Snippet: Wound infections pose a significant challenge in healthcare, and traditional antibiotic treatments often result in the development of resistant pathogens.. Addressing this gap, we introduced ProGel, a living hydrogel created by entrapping probiotic Lactobacillus plantarum as a therapeutic component within a gelatin matrix.. With a double-syringe system, ProGel can be easily mixed and applied, conforming swiftly to any wound shape and forming hydrogel in situ.



    Similar Products

    94
    ATCC atcc 43390
    Atcc 43390, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/43390/Pseudomonas+aeruginosa+(Schroeter)+Migula/10__1038_slash_s44259___026___00252___1-184-1-1
    Average 94 stars, based on 1 article reviews
    atcc 43390 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    86
    Cell Signaling Technology Inc 43390s hamster anti cd11b
    43390s Hamster Anti Cd11b, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/43390/pm41635075-592-94-91
    Average 86 stars, based on 1 article reviews
    43390s hamster anti cd11b - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    93
    Santa Cruz Biotechnology lc3β sirna
    Lc3β Sirna, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/43390/MAP+LC3%CE%B2+siRNA/pm39907116-36-3-11
    Average 93 stars, based on 1 article reviews
    lc3β sirna - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    93
    Santa Cruz Biotechnology lc3b
    Contribution of apoptosis and autophagy to PF-429242/chloroquine (CQ)-induced cell death. (A) PLC5 and HepG2 cells were treated for 48 h with 10 µM PF-429242, 20 µM CQ, their combination (10 µM PF-429242 + 20 µM CQ), or 0.5 µM doxorubicin (DX, for PLC5 cells). Protein expression levels were analyzed via Western blotting. (B) PLC5 and HepG2 cells were transfected with <t>LC3B</t> siRNA for 24 h, followed by treatment with 20 µM PF-429242 for an additional 24 h. Western blotting was used to assess protein expression levels. (C) LC3B siRNA-transfected PLC5 and HepG2 cells were replated in 96-well plates and treated with a combination of 10 µM PF-429242 and 20 µM CQ (PF/CQ) for 72 h. Cell viability was evaluated using alamarBlue staining.
    Lc3b, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/43390/MAP+LC3%CE%B2+siRNA/pmc12163423-60-15-28
    Average 93 stars, based on 1 article reviews
    lc3b - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    92
    ATCC p aeruginosa
    Antimicrobial Efficacy of the ProGels against Common Wound Pathogens. A–C) These panels present the viability of common wound pathogens— P. <t>aeruginosa</t> , S. aureus , and C. albicans —after coincubating for 24 h with hydrogels, either loaded or unloaded with entrapped L. plantarum . The ProGel, with a high probiotic concentration (OD = 5), effectively eradicated both bacterial pathogens ( P. aeruginosa , S. aureus , A and B). Even the hydrogel with a lower probiotic load (OD = 0.5) managed to fully eliminate P. aeruginosa , while reducing S. aureus by roughly 3log CFU. C) The antifungal effect of the ProGels against C. albicans was not as strong as its antibacterial power, an elevation in the probiotic load within the hydrogel correlated with augmented antifungal activity, effectuating a reduction of 40% and 70% for a hydrogel with low (OD = 0.5) and high (OD = 5) probiotic loads, respectively. D–F) The agar diffusion assay demonstrates the hydrogel's antimicrobial properties against the mentioned pathogens. Notably, clear inhibition zones (indicated with the arrows and dotted circle) are visible against bacterial pathogens with the ProGels (D and E), especially those with higher probiotic loads. However, no significant inhibition zones were observed for C. albicans (F). *** denotes statistical difference ( P < 0.001) and ** ( P < 0.01) using the ANOVA test. n = 3 (biological repeats), mean ± SD shown.
    P Aeruginosa, supplied by ATCC, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/43390/Pseudomonas+aeruginosa/pmc12344615-199-5-7
    Average 92 stars, based on 1 article reviews
    p aeruginosa - by Bioz Stars, 2026-11
    92/100 stars
      Buy from Supplier

    93
    Santa Cruz Biotechnology map lc 3β
    Antimicrobial Efficacy of the ProGels against Common Wound Pathogens. A–C) These panels present the viability of common wound pathogens— P. <t>aeruginosa</t> , S. aureus , and C. albicans —after coincubating for 24 h with hydrogels, either loaded or unloaded with entrapped L. plantarum . The ProGel, with a high probiotic concentration (OD = 5), effectively eradicated both bacterial pathogens ( P. aeruginosa , S. aureus , A and B). Even the hydrogel with a lower probiotic load (OD = 0.5) managed to fully eliminate P. aeruginosa , while reducing S. aureus by roughly 3log CFU. C) The antifungal effect of the ProGels against C. albicans was not as strong as its antibacterial power, an elevation in the probiotic load within the hydrogel correlated with augmented antifungal activity, effectuating a reduction of 40% and 70% for a hydrogel with low (OD = 0.5) and high (OD = 5) probiotic loads, respectively. D–F) The agar diffusion assay demonstrates the hydrogel's antimicrobial properties against the mentioned pathogens. Notably, clear inhibition zones (indicated with the arrows and dotted circle) are visible against bacterial pathogens with the ProGels (D and E), especially those with higher probiotic loads. However, no significant inhibition zones were observed for C. albicans (F). *** denotes statistical difference ( P < 0.001) and ** ( P < 0.01) using the ANOVA test. n = 3 (biological repeats), mean ± SD shown.
    Map Lc 3β, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/43390/MAP+LC3%CE%B2+(h)-PR/10__1080_slash_13102818__2023__2293055-93-26-29
    Average 93 stars, based on 1 article reviews
    map lc 3β - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    94
    ATCC delta variant
    Antimicrobial Efficacy of the ProGels against Common Wound Pathogens. A–C) These panels present the viability of common wound pathogens— P. <t>aeruginosa</t> , S. aureus , and C. albicans —after coincubating for 24 h with hydrogels, either loaded or unloaded with entrapped L. plantarum . The ProGel, with a high probiotic concentration (OD = 5), effectively eradicated both bacterial pathogens ( P. aeruginosa , S. aureus , A and B). Even the hydrogel with a lower probiotic load (OD = 0.5) managed to fully eliminate P. aeruginosa , while reducing S. aureus by roughly 3log CFU. C) The antifungal effect of the ProGels against C. albicans was not as strong as its antibacterial power, an elevation in the probiotic load within the hydrogel correlated with augmented antifungal activity, effectuating a reduction of 40% and 70% for a hydrogel with low (OD = 0.5) and high (OD = 5) probiotic loads, respectively. D–F) The agar diffusion assay demonstrates the hydrogel's antimicrobial properties against the mentioned pathogens. Notably, clear inhibition zones (indicated with the arrows and dotted circle) are visible against bacterial pathogens with the ProGels (D and E), especially those with higher probiotic loads. However, no significant inhibition zones were observed for C. albicans (F). *** denotes statistical difference ( P < 0.001) and ** ( P < 0.01) using the ANOVA test. n = 3 (biological repeats), mean ± SD shown.
    Delta Variant, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/43390/Pseudomonas+aeruginosa+(Schroeter)+Migula/pm37891503-67-4-30
    Average 94 stars, based on 1 article reviews
    delta variant - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    Image Search Results


    Contribution of apoptosis and autophagy to PF-429242/chloroquine (CQ)-induced cell death. (A) PLC5 and HepG2 cells were treated for 48 h with 10 µM PF-429242, 20 µM CQ, their combination (10 µM PF-429242 + 20 µM CQ), or 0.5 µM doxorubicin (DX, for PLC5 cells). Protein expression levels were analyzed via Western blotting. (B) PLC5 and HepG2 cells were transfected with LC3B siRNA for 24 h, followed by treatment with 20 µM PF-429242 for an additional 24 h. Western blotting was used to assess protein expression levels. (C) LC3B siRNA-transfected PLC5 and HepG2 cells were replated in 96-well plates and treated with a combination of 10 µM PF-429242 and 20 µM CQ (PF/CQ) for 72 h. Cell viability was evaluated using alamarBlue staining.

    Journal: International Journal of Medical Sciences

    Article Title: The combination of PF-429242 and chloroquine triggers pH-dependent cell death in hepatocellular carcinoma cells

    doi: 10.7150/ijms.109069

    Figure Lengend Snippet: Contribution of apoptosis and autophagy to PF-429242/chloroquine (CQ)-induced cell death. (A) PLC5 and HepG2 cells were treated for 48 h with 10 µM PF-429242, 20 µM CQ, their combination (10 µM PF-429242 + 20 µM CQ), or 0.5 µM doxorubicin (DX, for PLC5 cells). Protein expression levels were analyzed via Western blotting. (B) PLC5 and HepG2 cells were transfected with LC3B siRNA for 24 h, followed by treatment with 20 µM PF-429242 for an additional 24 h. Western blotting was used to assess protein expression levels. (C) LC3B siRNA-transfected PLC5 and HepG2 cells were replated in 96-well plates and treated with a combination of 10 µM PF-429242 and 20 µM CQ (PF/CQ) for 72 h. Cell viability was evaluated using alamarBlue staining.

    Article Snippet: After transfection for 24-48 h, cells were used for further experiments. siRNA specific for the LC3B (#sc-43390), ATP6V0D1 (#sc-63207), MBTPS1 (#sc-36496), and MBTPS2 (#sc-41652) genes were purchased from Santa Cruz Technology. pEGFP-STAT3 (#111934), pcDNA3-SREBP1a (#26801), pcDNA3-SREBP1c (#26802), and pcDNA3-SREBP2 (#26807) plasmids were purchased from Addgene.

    Techniques: Expressing, Western Blot, Transfection, Staining

    Antimicrobial Efficacy of the ProGels against Common Wound Pathogens. A–C) These panels present the viability of common wound pathogens— P. aeruginosa , S. aureus , and C. albicans —after coincubating for 24 h with hydrogels, either loaded or unloaded with entrapped L. plantarum . The ProGel, with a high probiotic concentration (OD = 5), effectively eradicated both bacterial pathogens ( P. aeruginosa , S. aureus , A and B). Even the hydrogel with a lower probiotic load (OD = 0.5) managed to fully eliminate P. aeruginosa , while reducing S. aureus by roughly 3log CFU. C) The antifungal effect of the ProGels against C. albicans was not as strong as its antibacterial power, an elevation in the probiotic load within the hydrogel correlated with augmented antifungal activity, effectuating a reduction of 40% and 70% for a hydrogel with low (OD = 0.5) and high (OD = 5) probiotic loads, respectively. D–F) The agar diffusion assay demonstrates the hydrogel's antimicrobial properties against the mentioned pathogens. Notably, clear inhibition zones (indicated with the arrows and dotted circle) are visible against bacterial pathogens with the ProGels (D and E), especially those with higher probiotic loads. However, no significant inhibition zones were observed for C. albicans (F). *** denotes statistical difference ( P < 0.001) and ** ( P < 0.01) using the ANOVA test. n = 3 (biological repeats), mean ± SD shown.

    Journal: Advanced Healthcare Materials

    Article Title: An Injectable Living Hydrogel with Embedded Probiotics as a Novel Strategy for Combating Multifaceted Pathogen Wound Infections

    doi: 10.1002/adhm.202400921

    Figure Lengend Snippet: Antimicrobial Efficacy of the ProGels against Common Wound Pathogens. A–C) These panels present the viability of common wound pathogens— P. aeruginosa , S. aureus , and C. albicans —after coincubating for 24 h with hydrogels, either loaded or unloaded with entrapped L. plantarum . The ProGel, with a high probiotic concentration (OD = 5), effectively eradicated both bacterial pathogens ( P. aeruginosa , S. aureus , A and B). Even the hydrogel with a lower probiotic load (OD = 0.5) managed to fully eliminate P. aeruginosa , while reducing S. aureus by roughly 3log CFU. C) The antifungal effect of the ProGels against C. albicans was not as strong as its antibacterial power, an elevation in the probiotic load within the hydrogel correlated with augmented antifungal activity, effectuating a reduction of 40% and 70% for a hydrogel with low (OD = 0.5) and high (OD = 5) probiotic loads, respectively. D–F) The agar diffusion assay demonstrates the hydrogel's antimicrobial properties against the mentioned pathogens. Notably, clear inhibition zones (indicated with the arrows and dotted circle) are visible against bacterial pathogens with the ProGels (D and E), especially those with higher probiotic loads. However, no significant inhibition zones were observed for C. albicans (F). *** denotes statistical difference ( P < 0.001) and ** ( P < 0.01) using the ANOVA test. n = 3 (biological repeats), mean ± SD shown.

    Article Snippet: L. plantarum (ATCC 10 241), P. aeruginosa (ATCC 43 390), S. aureus (ATCC 6538), and C. albicans (ATCC 90 028) were purchased from the Leibniz Institute DSMZ.

    Techniques: Concentration Assay, Activity Assay, Diffusion-based Assay, Inhibition

    Cytotoxicity and hemocompatibility of ProGel. A) Hydrogel extracts (24 and 48 h) maintained high cell viability, indicating excellent cytocompatibility. B) nHDFs cocultured with L. plantarum showed no cytotoxicity, unlike those with P. aeruginosa and S. aureus , confirmed by the CCK‐8 assay. C) Microscopy shows detached, round dead cells in cultures with P. aeruginosa and S. aureus , while cells with L. plantarum remained intact. Scale bar = 100 µm. D) A transwell (0.4 µm pore size) allowed the separation of components, ensuring signals from nHDFs only. E) CCK‐8 assay results show no cytotoxicity from the living hydrogel after one day of coculture. F) Hemolysis assay results indicate all tested materials, except the Triton‐X control, had hemolysis rates below the 2% safety threshold, confirming hemocompatibility. *** denotes statistical significance ( P < 0.0001) using ANOVA test. n = 3 (biological repeats), mean ± SD shown.

    Journal: Advanced Healthcare Materials

    Article Title: An Injectable Living Hydrogel with Embedded Probiotics as a Novel Strategy for Combating Multifaceted Pathogen Wound Infections

    doi: 10.1002/adhm.202400921

    Figure Lengend Snippet: Cytotoxicity and hemocompatibility of ProGel. A) Hydrogel extracts (24 and 48 h) maintained high cell viability, indicating excellent cytocompatibility. B) nHDFs cocultured with L. plantarum showed no cytotoxicity, unlike those with P. aeruginosa and S. aureus , confirmed by the CCK‐8 assay. C) Microscopy shows detached, round dead cells in cultures with P. aeruginosa and S. aureus , while cells with L. plantarum remained intact. Scale bar = 100 µm. D) A transwell (0.4 µm pore size) allowed the separation of components, ensuring signals from nHDFs only. E) CCK‐8 assay results show no cytotoxicity from the living hydrogel after one day of coculture. F) Hemolysis assay results indicate all tested materials, except the Triton‐X control, had hemolysis rates below the 2% safety threshold, confirming hemocompatibility. *** denotes statistical significance ( P < 0.0001) using ANOVA test. n = 3 (biological repeats), mean ± SD shown.

    Article Snippet: L. plantarum (ATCC 10 241), P. aeruginosa (ATCC 43 390), S. aureus (ATCC 6538), and C. albicans (ATCC 90 028) were purchased from the Leibniz Institute DSMZ.

    Techniques: CCK-8 Assay, Microscopy, Pore Size, Hemolysis Assay, Control

    A) Histological Analysis of the Antibiofilm Efficacy of Hydrogels Tested with an Ex vivo Skin Model. Artificial wounds of 6 mm diameter were created on human ex vivo skin samples of 13 mm diameter (A), followed by deliberate infection with P. aeruginosa (OD = 0.1) or S. aureus (OD = 0.5). Both unloaded and L. plantarum loaded hydrogel samples were applied on these infected wounds and subjected to treatment for 24 h ( P. aeruginosa ) and 48 h ( S. aureus ). Panels (B‐D) feature skin samples post‐ P. aeruginosa infection, B) untreated, C) treated with blank hydrogel, and D) L. plantarum loaded hydrogel. Panels (E–G) correspondingly display skin samples post‐ S. aureus infection, E) untreated, F) blank hydrogel treated, and G) L. plantarum loaded hydrogel treated. In the untreated groups, prominent clusters of B) P. aeruginosa and E) S. aureus biofilms were discernible on the dermis. Notably, while the blank hydrogel significantly F) curbed S. aureus biofilm formation, C) its effects against P. aeruginosa biofilms were inconsequential. With the ProGel treatment, the presence of biofilms was virtually absent (D, G), thereby reinforcing the potency of the living hydrogel against both pathogens. [Scale bar = 200 µm].

    Journal: Advanced Healthcare Materials

    Article Title: An Injectable Living Hydrogel with Embedded Probiotics as a Novel Strategy for Combating Multifaceted Pathogen Wound Infections

    doi: 10.1002/adhm.202400921

    Figure Lengend Snippet: A) Histological Analysis of the Antibiofilm Efficacy of Hydrogels Tested with an Ex vivo Skin Model. Artificial wounds of 6 mm diameter were created on human ex vivo skin samples of 13 mm diameter (A), followed by deliberate infection with P. aeruginosa (OD = 0.1) or S. aureus (OD = 0.5). Both unloaded and L. plantarum loaded hydrogel samples were applied on these infected wounds and subjected to treatment for 24 h ( P. aeruginosa ) and 48 h ( S. aureus ). Panels (B‐D) feature skin samples post‐ P. aeruginosa infection, B) untreated, C) treated with blank hydrogel, and D) L. plantarum loaded hydrogel. Panels (E–G) correspondingly display skin samples post‐ S. aureus infection, E) untreated, F) blank hydrogel treated, and G) L. plantarum loaded hydrogel treated. In the untreated groups, prominent clusters of B) P. aeruginosa and E) S. aureus biofilms were discernible on the dermis. Notably, while the blank hydrogel significantly F) curbed S. aureus biofilm formation, C) its effects against P. aeruginosa biofilms were inconsequential. With the ProGel treatment, the presence of biofilms was virtually absent (D, G), thereby reinforcing the potency of the living hydrogel against both pathogens. [Scale bar = 200 µm].

    Article Snippet: L. plantarum (ATCC 10 241), P. aeruginosa (ATCC 43 390), S. aureus (ATCC 6538), and C. albicans (ATCC 90 028) were purchased from the Leibniz Institute DSMZ.

    Techniques: Ex Vivo, Infection